Double-Detargeted Oncolytic Adenovirus Shows Replication Arrest in Liver Cells and Retains Neuroendocrine Cell Killing Ability

BACKGROUND: We have previously developed an oncolytic serotype 5 adenovirus (Ad5) with chromogranin-A (CgA) promoter-controlled E1A expression, Ad[CgA-E1A], with the intention to treat neuroendocrine tumors, including carcinoids. Since carcinoids tend to metastasize to the liver it is important to f...

Descripción completa

Detalles Bibliográficos
Autores principales: Leja, Justyna, Nilsson, Berith, Yu, Di, Gustafson, Elisabet, Åkerström, Göran, Öberg, Kjell, Giandomenico, Valeria, Essand, Magnus
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2811733/
https://www.ncbi.nlm.nih.gov/pubmed/20111709
http://dx.doi.org/10.1371/journal.pone.0008916

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2811733/
https://www.ncbi.nlm.nih.gov/pubmed/20111709
http://dx.doi.org/10.1371/journal.pone.0008916

Ejemplares similares